Email updates

Keep up to date with the latest news and content from BMC Pharmacology and Toxicology and BioMed Central.

Open Access Highly Accessed Pre-publication history

A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study

Suzanne Dunne*, Bill Shannon, Colum Dunne and Walter Cullen

BMC Pharmacology and Toxicology 2013, 14:1  doi:10.1186/2050-6511-14-1

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 21 Mar 2012
Reviewer's Report Zaheer Babar 07 May 2012
Reviewer's Report Atholl Johnston 01 Jun 2012
Reviewer's Report Brian Godman 07 Jun 2012
Reviewer's Report Brian Godman 07 Jun 2012
Resubmission - Version 2 Author's comment 31 Aug 2012
Reviewer's Report Brian Godman 05 Oct 2012
Reviewer's Report Atholl Johnston 05 Oct 2012
Reviewer's Report Zaheer Babar 11 Oct 2012
Resubmission - Version 3 Manuscript Author's comment 20 Nov 2012
Resubmission - Version 4 Manuscript 14 Dec 2012
Resubmission - Version 5 Manuscript Author's comment 22 Dec 2012
Editorial acceptance 24 Dec 2012
Published 05 Jan 2013